Valion Bio Inc (VBIO) Peer Comparison

$2.80

$-0.03 (-1.06%)

As on 30-Sep-2026 16:29EDT

Market cap

$3 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Market cap ($ Mln)	3	4,736	3,349	10
Revenue ($ Mln)	2	1,206	573	6
Net Profit ($ Mln)	-18.75	134.79	147.29	0.07
Net Margin (%)	-1,003.19	11.18	25.72	1.20
RoE (%)	-130.74	3.43	25.36	--
Price to Earnings	--	35.29	23.90	--
Price-To-Book	0.52	1.19	5.41	1,802.81

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Operating Revenue	1.87	1,205.74	572.56	2.05
Cost of Revenue	0.65	372.49	128.30	1.39
Gross Profit	0.03	751.12	380.84	0.66
Operating Expenses	15.71	557.49	437.75	0.93
Operating Profit (EBIT)	-16.52	275.76	6.51	-0.27
Other Income	0.00	0.00	0.00	--
Profit before Tax	-17.84	195.08	14.06	-0.28
Provision for Tax	0.00	60.29	-133.23	--
Profit after Tax (Net Income)	-18.75	134.79	147.29	-0.28
Minority Interest	0.00	0.00	0.00	--
Consolidated Profit	0.00	0.00	0.00	--

Liabilities ($ Mln)

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Shareholder's Funds	11.89	3,986.24	613.43	-0.17
Minority Interest	0.00	0.00	0.00	--
Non-Current Liabilities	17.54	1,644.80	331.45	0.37
Current Liabilities	3.05	237.72	107.04	0.51
Total Liabilities	31.61	5,785.10	959.69	0.71

Assets ($ Mln)

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Non-Current Assets	29.09	5,429.79	452.42	0.26
Current Assets	3.38	438.97	599.50	0.45
Total Assets	31.61	5,785.10	959.69	0.71
Total Debt*	17.41	1,481.72	311.48	0.35
Net Current Assets	0.34	201.25	492.46	-0.14

Cashflow ($ Mln)

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Cash From Operating Activities	-7.00	309.67	88.63	-0.21
Cash Flow from Investing Activities	-0.71	-680.90	-35.33	--
Cash from Financing Activities	18.35	243.45	282.07	0.16
Net Cash Inflow / Outflow	--	--	--	--

Ratios

Profitability Ratios

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
ROCE (%)	-68.86	2.31	24.76	-2,636.14
ROE (%)	-130.74	3.43	25.36	170.10
ROA (%)	-91.80	2.46	14.84	-39.73
EBIT Margin (%)	-745.03	22.87	2.46	--
Net Margin (%)	-1,003.19	11.18	25.72	-13.81
Cash Profit Margin (%)	0.00	0.00	0.00	--

Growth Ratios

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Revenue Growth (%)	376.80	19.23	33.96	0.00
EBIT Growth (%)	-121.70	31.10	-29.77	--
Net Profit Growth (%)	-195.69	56.83	434.21	0.00
EPS Growth (%)	6.93	47.40	421.74	--
Book Value Growth (%)	2,001.23	17.28	65.12	--

Valuation Ratios

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Price / Earnings	-0.04	57.66	36.22	--
Price / Book Value	0.02	1.67	9.97	--
Dividend Yield (%)	--	--	--	--
EV/EBITDA	0.75	20.18	113.94	--
Market Cap ($ Cr)	--	--	--	--

Solvency Ratios

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Debt to Equity	0.62	0.36	0.51	-2.13
Short term debt to equity ratio	0.04	0.00	0.00	-0.75
Current Ratio	1.11	1.85	5.60	0.88
Quick Ratio	0.86	1.84	5.46	--
Interest Coverage	-11.95	3.42	--	-31.30

Operating Efficiency Ratios

	Valion Bio Inc (VBIO)	Waystar Holding Corp. (WAY)	Life360, Inc. (LIF)	Morningstar US Mid Cap PR USD (MMCP)
Debtors to sales (%)	76.95	15.42	17.21	--
Asset Turnover	0.09	0.22	0.58	2.88
Receivable days	33.47	55.08	53.89	--
Inventory Days	332.90	--	30.13	--
Payable days	202.97	51.57	23.32	80.44
Cash Conversion Cycle	163.39	--	60.70	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly